Activatable Cell Penetrating Peptide–Peptide Nucleic Acid Conjugate via Reduction of Azobenzene PEG Chains-Reference-Cited by-同舟云学术

Activatable Cell Penetrating Peptide–Peptide Nucleic Acid Conjugate via Reduction of Azobenzene PEG Chains

Published:2014-09-08 Issue:37 Volume:136 Page:12868-12871
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Lee Soo Hyeon¹,Moroz Elena¹,Castagner Bastien¹,Leroux Jean-Christophe¹

Affiliation:

1. Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zurich (ETHZ), Zurich 8093, Switzerland

Funder

Gebert Rüf Stiftung

Nagai Foundation Tokyo

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/ja507547w

Reference37 articles.

1. Is there a future for cell-penetrating peptides in oligonucleotide delivery?

2. Chemically modified cell-penetrating peptides for the delivery of nucleic acids

3. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

4. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration

5. Transvascular delivery of small interfering RNA to the central nervous system

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor microenvironment-responsive cell-penetrating peptides: Design principle and precision delivery;Colloids and Surfaces B: Biointerfaces;2024-10

2. Enzyme-catalyzed molecular MR imaging of tumors;TrAC Trends in Analytical Chemistry;2024-09

3. Cell-Penetrating Peptide-Mediated Biomolecule Transportation in Artificial Lipid Vesicles and Living Cells;Molecules;2024-07-16

4. Rational design of polymeric micelles for targeted therapeutic delivery;Nano Today;2024-04

5. Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity;MedComm;2024-03